Cingulate Therapeutics LLC has a total of 14 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals are DONGFANG HOSPITAL BEIJING UNIVERSITY OF CHINESE MEDICINE, ELLIPTICAL THERAPEUTICS LLC and SSP CO LTD JAPAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Brams Matthew | 10 |
#2 | Straughn Arthur | 10 |
#3 | Silva Raul | 10 |
#4 | Raul Silva | 3 |
#5 | Arthur Straughn | 3 |
#6 | Matthew Brams | 3 |
Publication | Filing date | Title |
---|---|---|
AU2016225052A1 | Tripulse release stimulant formulations |